SCHEMBL1853871

SCHEMBL1853871

C=CCNc1ccc(Br)cn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.57
NPC1 O15118 5/20 0.53
SMN1; SMN2 Q16637 3/20 0.48
ALDH1A1 P00352 3/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPK1 P28482 1/20 0.48
RAB9A P51151 5/20 0.47
PKM P14618 3/20 0.47
HPGD P15428 3/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 2/20 0.46
MTOR P42345 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
MAPT P10636 4/20 0.45
ATM Q13315 1/20 0.44
GFER P55789 1/20 0.42
HIF1A Q16665 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8230644 0.78 HCAR3 (0.57) HCAR3NPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL28334037 0.78 HCAR3 (0.57) HCAR3NPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL28602075 0.76 NPC1 (0.50) NPC1SMN1; SMN2ALDH1A1KDM4EMAPK1
SCHEMBL1855199 0.76 HCAR3 (0.46) HCAR3NPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL22606744 0.75 HCAR3 (0.54) HCAR3NPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL1853374 0.75 INSR (0.43) HCAR3NPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL503269 0.75 NPC1 (0.55) HCAR3NPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL24616542 0.74 HCAR3 (0.53) HCAR3NPC1ALDH1A1KDM4ERAB9A
SCHEMBL22606741 0.74 HCAR3 (0.53) HCAR3NPC1SMN1; SMN2ALDH1A1RAB9A
Hydrochloric Acid SCHEMBL2713140 0.73 NPC1 (0.54) HCAR3NPC1SMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853420-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-10-07 US disclosed
EP-2471787-A1 New compounds Boehringer Ingelheim International GmbH (DE) 2012-07-04 EP disclosed
US-20110263565-A1 COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-27 US disclosed
EP-2324012-A1 NEW COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2011-05-25 EP disclosed
WO-2010012747-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263565-A1 COMPOUNDS MKI67, CCNA1, CCNT1 HCAR3 3198/4885NPC1 81/4885SMN1; SMN2 393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.